Literature DB >> 12447522

Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients.

Michael Darmon1, Elie Azoulay, Corinne Alberti, Fabienne Fieux, Delphine Moreau, Jean-Roger Le Gall, Benoît Schlemmer.   

Abstract

OBJECTIVE: To identify predictors of 30-day mortality and to assess the impact of neutropenia recovery (NR) on 30-day mortality in critically ill cancer patients (CICPs). DESIGN AND
SETTING: Retrospective review of the medical records of the 102 neutropenic CICPs admitted to a medical intensive care unit (ICU) over a 10-year period. INTERVENTION: None. MEASUREMENTS AND
RESULTS: Malignancies consisted of acute leukemia (n=42), lymphoma (n=23), myeloma (n=28), and solid tumors (n=9). Reasons for ICU admission were acute respiratory failure (n=81), shock (n=58), acute renal failure (n=33), and coma (n=13). Seventy patients needed conventional mechanical ventilation (MV) and 21 noninvasive MV, 67 vasopressor agents, and 28 dialysis. Sixty-two patients experienced NR during their ICU stay. In a multivariate logistic regression model, 30-day mortality was higher in patients with acute respiratory or renal failure and lower in patients with NR (OR, 0.09 [0.01-0.86]). This model assumed that patients who experienced NR in the ICU were merely these who did not die early in the ICU. To take into account the effect of time to occurrence of NR on time to death we secondarily used a Cox model including neutropenia duration and NR as time-dependent variables. In this second model, the only significant predictors of 30-day mortality were age, respiratory failure, renal failure, and coma.
CONCLUSION: Organ failure but not disease progression or neutropenia duration affect 30-day mortality in neutropenic CICPs. ICU-acquired events might be modeled as time-dependent variables in a Cox model, rather than standard covariates in logistic regression models.

Entities:  

Mesh:

Year:  2002        PMID: 12447522     DOI: 10.1007/s00134-002-1528-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  33 in total

Review 1.  Diagnostic strategy in cancer patients with acute respiratory failure.

Authors:  Elie Azoulay; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2006-04-29       Impact factor: 17.440

2.  Critical care management of lung cancer patients to prolong life without prolonging dying.

Authors:  Márcio Soares; Elie Azoulay
Journal:  Intensive Care Med       Date:  2009-09-19       Impact factor: 17.440

3.  Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.

Authors:  Nicole M Kuderer; Gary H Lyman
Journal:  J Natl Cancer Inst       Date:  2011-06-13       Impact factor: 13.506

4.  Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU.

Authors:  B Lamia; M-F Hellot; C Girault; F Tamion; F Dachraoui; P Lenain; G Bonmarchand
Journal:  Intensive Care Med       Date:  2006-08-01       Impact factor: 17.440

5.  Improved outcome of critically ill patients with hematological malignancies: what's next?

Authors:  Ayman O Soubani; Johan Decruyenaere
Journal:  Intensive Care Med       Date:  2014-08-01       Impact factor: 17.440

Review 6.  The Intensive Care Medicine research agenda on critically ill oncology and hematology patients.

Authors:  Elie Azoulay; Peter Schellongowski; Michael Darmon; Philippe R Bauer; Dominique Benoit; Pieter Depuydt; Jigeeshu V Divatia; Virginie Lemiale; Maarten van Vliet; Anne-Pascale Meert; Djamel Mokart; Stephen M Pastores; Anders Perner; Frédéric Pène; Peter Pickkers; Kathryn A Puxty; Francois Vincent; Jorge Salluh; Ayman O Soubani; Massimo Antonelli; Thomas Staudinger; Michael von Bergwelt-Baildon; Marcio Soares
Journal:  Intensive Care Med       Date:  2017-07-19       Impact factor: 17.440

7.  Central neurological complications in critically ill patients with malignancies.

Authors:  Stéphane Legriel; Hélène Marijon; Michael Darmon; Virginie Lemiale; Jean-Pierre Bedos; Benoît Schlemmer; Elie Azoulay
Journal:  Intensive Care Med       Date:  2009-11-12       Impact factor: 17.440

8.  Cytotoxic chemotherapy administered to two patients with partially refractory leukaemia while receiving intensive care treatment.

Authors:  K A Al-Anazi; S Jacobs
Journal:  Support Care Cancer       Date:  2004-10       Impact factor: 3.603

Review 9.  [Chronic critically ill patients from the perspective of hematologists/oncologists].

Authors:  T Staudinger; P Schellongowski
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-02-28       Impact factor: 0.840

10.  Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database.

Authors:  Peter A Hampshire; Catherine A Welch; Lawrence A McCrossan; Katharine Francis; David A Harrison
Journal:  Crit Care       Date:  2009-08-25       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.